⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1870979 | 0.84 | TP53 (0.39) | — | |
| SCHEMBL17297099 | 0.79 | ALDH1A1 (0.33) | — | |
| SCHEMBL605423 | 0.79 | — | — | |
| SCHEMBL1526200 | 0.78 | TP53 (0.30) | — | |
| SCHEMBL12207153 | 0.74 | TAS1R3 (0.42) | — | |
| SCHEMBL21568355 | 0.74 | TAS1R3 (0.42) | — | |
| SCHEMBL14853536 | 0.74 | — | — | |
| SCHEMBL28791993 | 0.74 | — | — | |
| SCHEMBL3076185 | 0.74 | — | — | |
| SCHEMBL19521114 | 0.72 | ALDH1A1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023081765-A2 | PRODRUG COPOLYMERS AND POLYMERIC MICELLES THEREOF FOR THE DELIVERY OF SHORT-CHAIN FATTY ACIDS, THE PROMOTION OF GUT HEALTH, AND THE TREATMENT OF IMMUNE AND/OR INFLAMMATORY CONDITIONS AND FOOD ALLERGY | THE UNIVERSITY OF CHICAGO (US) | 2023-05-11 | — | — | WO | disclosed |
| US-20230012485-A1 | ADHESIVE DEVICE FOR BIOMEDICAL APPLICATIONS AND METHODS OF USE THEREOF | SUNNYBROOK HEALTH SCIENCES CENTRE (CA) | 2023-01-19 | — | — | US | disclosed |
| US-20230001046-A1 | BIOCOMPATIBLE ADHESIVES AND METHODS OF MANUFACTURE THEREOF | GOVERNING COUNCIL UNIV TORONTO (CA) | 2023-01-05 | — | — | US | disclosed |
| US-20220395608-A1 | WATER SOLUBLE BIOADHESIVES | GOVERNING COUNCIL UNIV TORONTO (CA) | 2022-12-15 | — | — | US | disclosed |
| WO-2018089261-A2 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |